Drugs Made In America Acquisition II Corp. Unit
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company.
AI analysis
An AI analyst reads Drugs Made In America Acquisition II Corp. Unit's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2025 |
|---|---|
| 0 | |
| – | |
| -1 | |
| -1 | |
| 4 | |
| – | |
| – | |
| – | |
| – |
Balance sheet
| In millions of USD | 2025 |
|---|---|
| Total assets | 505 |
| Cash | 0 |
| Total debt | – |
| Total liabilities | 18 |
| 487 | |
| – | |
| -0.2% | |
| 0.9% |
Cash flow
| In millions of USD | 2025 |
|---|---|
| -1 | |
| – | |
| -1 | |
| Dividends paid | – |
| – | |
| – |
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision lossMarketWatch · Nov 9, 2026Generate, Zealand in collaboration to develop drugs for obesity, metabolic diseasesSeeking Alpha · Oct 13, 2026As GLP-1 Drugs Change How People Eat, Drugmakers Collect and Snack Makers Feel the SqueezeYahoo Finance · Oct 11, 2026Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1sCNBC · Oct 2, 2026Beyond GLP-1 injectables, who wins the next phase for obesity drugs?Seeking Alpha · Sep 25, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Drugs Made In America Acquisition II Corp. Unit
Is Drugs Made In America Acquisition II Corp. Unit a good stock to buy?
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Drugs Made In America Acquisition II Corp. Unit AI analysis
What does Drugs Made In America Acquisition II Corp. Unit do?
A SPAC (blank check company) incorporated in the Cayman Islands to pursue a business combination. The company aims to focus on pharmaceutical / drug sector targets to reduce U.S. reliance on global drug manufacturing. It is in Asset Management.
Does Drugs Made In America Acquisition II Corp. Unit pay a dividend?
No. Drugs Made In America Acquisition II Corp. Unit does not pay a dividend at the moment.
How has Drugs Made In America Acquisition II Corp. Unit stock done over the past year?
Up 2.2% over the past twelve months, to $10.26. It traded between $9.99 and $10.26, close to its high.
Prices: daily closes to Nov 6, 2026. Fundamentals: company reports via invest-like data.